Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis-Reference-Cited by-同舟云学术

Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis

Published:2017-06-09 Issue:9 Volume:92 Page:879-884
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Bair Steven M.¹^ORCID,Strelec Lauren¹,Nagle Sarah J.¹,Nasta Sunita D.¹,Landsburg Daniel J.¹,Mato Anthony R.¹^ORCID,Loren Alison W.¹,Schuster Stephen J.¹,Stadtmauer Edward A.¹,Svoboda Jakub¹

Affiliation:

1. Hospital of the University of Pennsylvania, Department of Medicine; Division of Hematology/Oncology, Perelman Center for Advanced Medicine; Philadelphia Pennsylvania 19104

Publisher

Wiley

Subject

Hematology

Reference27 articles.

1. http://seer.cancer.gov/statfacts/html/hodg.html 2015

2. Autologous stem cell transplant for relapsed/refractory Hodgkin lymphoma: results from two transplant centres;Smith;Br J Haematol.,2011

3. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma;Majhail;Biol Blood Marrow Transplant.,2006

4. Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma;Sorohi;Ann Oncol.,2008

5. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantationfor relapsed chemosensitive Hodgkin's disease: a randomized trial;Schmitz;Lancet.,2002

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors;Journal of the National Cancer Center;2023-11

2. Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant;HemaSphere;2023-04

3. Immunotherapy for Hodgkin lymphoma: From monoclonal antibodies to chimeric antigen receptor T-cell therapy;Critical Reviews in Oncology/Hematology;2023-02

4. Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study;Cancers;2022-11-27

5. Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC study;Leukemia & Lymphoma;2022-10-06